Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study. - Green JR; Swan CH; Gibson JA; Kerr GD; Swarbrick ET; Thornton PC (Alimentary pharmacology & therapeutics, 2004)